Medicure Inc. (CVE:MPH – Get Free Report) crossed below its 50 day moving average during trading on Tuesday . The stock has a 50 day moving average of C$1.11 and traded as low as C$1.10. Medicure shares last traded at C$1.10, with a volume of 4,845 shares traded.
Medicure Price Performance
The firm has a fifty day moving average of C$1.11 and a 200 day moving average of C$1.04. The company has a market capitalization of C$11.48 million, a P/E ratio of -8.46 and a beta of 1.02. The company has a current ratio of 2.03, a quick ratio of 1.29 and a debt-to-equity ratio of 4.65.
Medicure Company Profile
Medicure Inc, a biopharmaceutical company, engages in the research, development, and commercialization of human therapies in the United States. The company markets and distributes AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction.
Featured Articles
- Five stocks we like better than Medicure
- How to Invest in Small Cap Stocks
- After Gold Blast Soars Past $4,000, BofA Eyes $5,000 in 2026
- Growth Stocks: What They Are, What They Are Not
- Buyback Boom: 3 Companies Betting Big on Themselves
- How to Use the MarketBeat Stock Screener
- Analysts Flock to Upgrade DELL After Big AI-Server Guidance Boost
Receive News & Ratings for Medicure Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medicure and related companies with MarketBeat.com's FREE daily email newsletter.
